Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the Clareon Family of intraocular lenses (IOLs) in India. Utilizing Alcon’s most advanced IOL material in its 20+ years of IOL innovation, Clareon delivers consistent visual outcomes and exceptional clarity that lasts.^°,12-18 Clareon’s clarity is born out of a glistening-free^§ IOL material that has among the lowest levels of haze and subsurface nanoglistenings (SSNGs), compared to leading competitor IOLs.^†,*,12-14

The Clareon platform is available in India in two PCIOL technologies:

• Clareon PanOptix, which delivers exceptional clarity and offers spectacle independence across all distances with a patient satisfaction rate of 99.2%^31-34;
• PanOptix Trifocal IOL, implanted over 2.2 million** times, making it the most widely implanted trifocal IOL in the world
• Clareon Vivity with wavefront-shaping X- WAVE technology, offering clinically proven exceptionally low rate of visual disturbances and unsurpassed clarity. 9 in 10 (90%) patients were satisfied with their visual outcome and said they would choose Clareon Vivity IOL again for themselves and recommend it for friends and family^4μ‖¶
• Vivity IOL, designed to extend vision and simplify the presbyopia-correcting experience for surgeons and patients while delivering monofocal- like certainty^1-11

“We are proud to offer the full range of our latest IOL technology to patients in India. At Alcon, we are consistently pushing the boundaries to deliver transformational innovation to cataract surgeons and their patients,” said Amar Vyas, Country Head of Alcon India. “Clareon builds on Alcon’s long legacy of IOL innovation and is the result of robust R&D efforts at every level—inventive material science, advanced manufacturing techniques and novel delivery systems. Our most advanced platform to date, Clareon delivers exceptional, long-lasting clarity.”

The Clareon portfolio leverages many of the same design characteristics and optics as Alcon’s leading IOLs to help deliver the outcomes surgeons expect.¹⁹ Clareon IOLs offer sharp, crisp vision with a proprietary edge designed to help reduce glare and posterior capsular opacification.¹³ The lens’ unique and proven STABLEFORCE Haptics provide superior axial and rotational stability.^*,β,19,20 Clareon IOLs have been extensively researched, with inclusions in 30 published studies worldwide.